Shenzhen:002603

Yiling's Lianhua Health Products Well-received: CICPE

SHIJIAZHUANG, China, Aug. 5, 2022 /PRNewswire/ -- As China's first national-level consumer expo and the largest such kind in theAsia-pacific region, the 2nd China International Consumer Products Expo (CICPE) attracted many audiences from different countries. And as the TOP 10 Chinese TCM Enterpr...

2022-08-05 15:54 4249

Yiling Pharmaceutical doubled its performance through innovation in 2020

SHIJIAZHUANG, China, April 12, 2021 /PRNewswire/ -- Yiling Pharmaceutical (002603.SZ) released its 2020 annual report on Thursday. It achieved an operating revenue ofRMB 8.782 billion in 2020, with a year-on-year growth of 50.76%; and net profit attributed to equity holders ofRMB 1.219 billion, w...

2021-04-12 17:07 4658

Yiling Pharma expects to double its YoY net profit in 2020

SHIJIAZHUANG, China, Jan. 6, 2021 /PRNewswire/ -- Yiling Pharmaceutical, a Shenzhen stock market listed enterprise (002603.SZ), has recently published its 2020 earnings projection. The yearly net profit belonging to its shareholders is anticipated to be between 1.152 billion Chinese yuan and 1.27...

2021-01-06 16:55 6902

TCM Lianhua Qingwen's Access to Russian Market Marks Its Global Expansion

SHIJIAZHUANG, China, Nov. 5, 2020 /PRNewswire/ -- Yiling Pharmaceutical (002603.SZ) discloses that it has received the Certificate of Registration for Dietary Supplements approved and issued by the authorized agency of Eurasian Economic Union, which indicates that the company's patent drug Lianhu...

2020-11-05 14:08 8070

Yiling Pharmaceutical: Revenue and Net Profit Attributable to the Parent Company for the First Three Quarters Already Exceeded the Full Year 2019

SHIJIAZHUANG, China, Oct. 28, 2020 /PRNewswire/ -- On October 27, Yiling Pharmaceutical (002603.SZ) released its 2020 third quarter report. In the first three quarters of the year, Yiling Pharmaceutical achieved the total operating revenue of6.447 billion yuan (about US$962 million), a 48.31% yea...

2020-10-28 17:04 6584

Yiling Pharmaceutical Reports 52.75% YOY Growth in R&D Investment, Boosting the Company's High Quality Development

SHIJIAZHUANG, China, Aug. 28, 2020 /PRNewswire/ -- Yiling Pharmaceutical (002603.SZ) on Thursday published its semiannual report of 2020. In the reporting period, the Company registered business revenues of4.487 billion RMB, a year-on-year growth of 50.35%; net profits earned by shareholders of t...

2020-08-28 18:27 11637

Sales of Cardio-Cerebrovascular Products and Lianhua Qingwen Surge, Yiling Pharmaceutical Predicting a 50% Increase in Half-year Net Profit

SHIJIAZHUANG, China, July 13, 2020 /PRNewswire/ -- In the evening of July 12, Yiling Pharmaceutical released the performance forecast for the first half year. In the first half of this year, the company achieved a net profit attributable to shareholders of 682 million to728 million Yuan (USD 97.4...

2020-07-13 12:25 12806

Yiling Pharmaceutical Lianhua Qingwen Capsule Extends Overseas Footprint in Southeast Asia

SHIJIAZHUANG, China, July 1, 2020 /PRNewswire/ -- Following Thailand, Singapore andIndonesia, Yiling Pharmaceutical (002603.SZ), a leader in the development of traditional Chinese medicines (TCM), obtained a Certificate of Registration issued by the Drug Department ofLaos' Ministry of Health whic...

2020-07-01 20:33 8927

Lianhua Qingwen Receives Product Listing Approval from Singapore HSA

SHIJIAZHUANG, China, May 7, 2020 /PRNewswire/ -- Yiling Pharmaceutical (002603.SZ) announced that it has obtained the product listing approval issued by the Health Sciences Authority (HSA) ofSingapore which grants Lianhua Qingwen Capsule the initial sale authorization in the country. The approval...

2020-05-07 15:14 63019

Yiling Pharmaceutical Releases Financial Report for Q1 2020, Covid-19 TCM Lianhua Qingwen Research and Achievements Drive Growth

SHIJIAZHUANG, China, May 6, 2020 /PRNewswire/ -- Yiling Pharmaceutical (002603.SZ) has released its financial report for the first quarter of 2020. In the March quarter, Yiling Pharmaceutical achieved a total operating revenue of CNY 2.334 billion (USD $329 million) with 50.56% growth year-on-year...

2020-05-06 17:52 10431

Lianhua Qingwen Approved and Registered by Ministry of Public Health of Ecuador as Natural Medicine

SHIJIAZHUANG, China, April 27, 2020 /PRNewswire/ -- Yiling Pharmaceutical (002603.SZ) has obtained approval from the Ministry of Public Health ofEcuador for the sale and promotion of the Lianhua Qingwen Capsule (Granule) ("Lianhua Qingwen") in the country. The approval officially registers Lianhu...

2020-04-27 20:43 2740

Lianhua Qingwen Listed in the Novel Coronavirus Pneumonia Diagnosis and Treatment Scheme for Laos

SHIJIAZHUANG, China, April 22, 2020 /PRNewswire/ -- Yiling Pharmaceutical (002603.SZ) announced that Lianhua Qingwen capsules (granules) have been added to the "Novel Coronavirus Pneumonia Diagnosis and Treatment Scheme forLaos" (Trial Version II) as the fourth traditional Chinese medicine to tre...

2020-04-23 20:00 6231